INR 43.14
(1.03%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 12.54 Million INR | -31.82% |
2022 | 21.38 Million INR | -26.81% |
2021 | 29.21 Million INR | -12.08% |
2020 | 33.23 Million INR | -24.15% |
2019 | 43.81 Million INR | 39.71% |
2018 | 31.36 Million INR | 21.14% |
2017 | 25.88 Million INR | -36.66% |
2016 | 40.87 Million INR | 127.85% |
2015 | 17.93 Million INR | 21.63% |
2014 | 14.74 Million INR | -22.07% |
2013 | 18.92 Million INR | 9.64% |
2012 | 17.25 Million INR | 230.62% |
2011 | 5.22 Million INR | 178.82% |
2010 | 1.87 Million INR | 53.46% |
2009 | 1.22 Million INR | -70.11% |
2008 | 4.08 Million INR | 41.98% |
2007 | 2.87 Million INR | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 4.9 Million INR | 277.15% |
2023 Q4 | 1.93 Million INR | -66.06% |
2023 FY | 14.57 Million INR | -31.82% |
2023 Q2 | 5.07 Million INR | -27.92% |
2023 Q3 | 5.68 Million INR | 12.08% |
2023 Q1 | 7.03 Million INR | 1.48% |
2022 Q1 | 6.47 Million INR | -31.75% |
2022 FY | 21.38 Million INR | -26.81% |
2022 Q4 | 6.93 Million INR | 64.06% |
2022 Q3 | 4.22 Million INR | 12.75% |
2022 Q2 | 3.75 Million INR | -42.06% |
2021 Q1 | 7 Million INR | -14.42% |
2021 Q3 | 7.29 Million INR | 3.23% |
2021 FY | 29.21 Million INR | -12.08% |
2021 Q4 | 9.48 Million INR | 29.96% |
2021 Q2 | 7.06 Million INR | 0.94% |
2020 Q3 | 11.28 Million INR | -16.36% |
2020 FY | 33.23 Million INR | -24.15% |
2020 Q1 | 273 Thousand INR | -98.08% |
2020 Q2 | 13.49 Million INR | 4842.49% |
2020 Q4 | 8.18 Million INR | -27.49% |
2019 Q3 | 8.34 Million INR | -44.55% |
2019 FY | 43.81 Million INR | 39.71% |
2019 Q1 | 6.84 Million INR | -36.04% |
2019 Q2 | 15.04 Million INR | 119.87% |
2019 Q4 | 14.25 Million INR | 70.84% |
2018 Q2 | 6.73 Million INR | 19.46% |
2018 FY | 31.36 Million INR | 21.14% |
2018 Q3 | 8.28 Million INR | 23.11% |
2018 Q1 | 5.63 Million INR | -54.56% |
2018 Q4 | 10.7 Million INR | 29.09% |
2017 Q1 | 3.12 Million INR | -87.41% |
2017 FY | 25.88 Million INR | -36.66% |
2017 Q4 | 12.4 Million INR | 95.97% |
2017 Q3 | 6.32 Million INR | 57.0% |
2017 Q2 | 4.03 Million INR | 28.87% |
2016 FY | 40.87 Million INR | 127.85% |
2016 Q1 | 2.21 Million INR | -88.19% |
2016 Q2 | 9.97 Million INR | 349.53% |
2016 Q3 | 12.62 Million INR | 26.56% |
2016 Q4 | 24.84 Million INR | 96.82% |
2015 Q2 | 2.17 Million INR | -18.04% |
2015 Q4 | 18.79 Million INR | 302.1% |
2015 Q3 | 4.67 Million INR | 115.15% |
2015 Q1 | 2.65 Million INR | -54.93% |
2015 FY | 17.93 Million INR | 21.63% |
2014 FY | 14.74 Million INR | -22.07% |
2014 Q4 | 5.87 Million INR | 60.3% |
2014 Q3 | 3.66 Million INR | -4.13% |
2014 Q2 | 3.82 Million INR | 178.66% |
2014 Q1 | 1.37 Million INR | 13.5% |
2013 FY | 18.92 Million INR | 9.64% |
2013 Q4 | 1.2 Million INR | -90.74% |
2013 Q1 | 2.45 Million INR | -78.56% |
2013 Q3 | 13.05 Million INR | 493.05% |
2013 Q2 | 2.2 Million INR | -10.23% |
2012 Q1 | 2.42 Million INR | 267.22% |
2012 FY | 17.25 Million INR | 230.62% |
2012 Q2 | 1.78 Million INR | -26.49% |
2012 Q3 | 1.61 Million INR | -9.48% |
2012 Q4 | 11.44 Million INR | 609.28% |
2011 Q3 | 2.05 Million INR | 0.0% |
2011 Q4 | -1.44 Million INR | -170.47% |
2011 FY | 5.22 Million INR | 178.82% |
2010 FY | 1.87 Million INR | 53.46% |
2009 FY | 1.22 Million INR | -70.11% |
2008 FY | 4.08 Million INR | 41.98% |
2008 Q4 | 2.37 Million INR | 0.0% |
2007 FY | 2.87 Million INR | 0.0% |
2007 Q4 | 1.73 Million INR | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Alembic Pharmaceuticals Limited | 26.78 Billion INR | 99.953% |
Hester Biosciences Limited | 1.27 Billion INR | 99.015% |
Aarti Drugs Limited | 8.31 Billion INR | 99.849% |
Aarti Pharmalabs Limited | 5.83 Billion INR | 99.785% |
Albert David Limited | 1.4 Billion INR | 99.109% |
Alembic Limited | 1 Billion INR | 98.746% |
Alkem Laboratories Limited | 52.29 Billion INR | 99.976% |
Bafna Pharmaceuticals Limited | 452.15 Million INR | 97.225% |
Bajaj HealthCare Limited | 1.47 Billion INR | 99.148% |
Brooks Laboratories Limited | 65.62 Million INR | 80.882% |
Eris Lifesciences Limited | 10.42 Billion INR | 99.88% |
FDC Limited | 6.58 Billion INR | 99.81% |
Glenmark Life Sciences Limited | 12.43 Billion INR | 99.899% |
Gufic Biosciences Limited | 4.07 Billion INR | 99.692% |
Hikal Limited | 5.95 Billion INR | 99.789% |
Ind-Swift Limited | 2.17 Billion INR | 99.423% |
Innova Captab Limited | 3.46 Billion INR | 99.638% |
IOL Chemicals and Pharmaceuticals Limited | 4.71 Billion INR | 99.734% |
Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | 98.078% |
Jubilant Pharmova Limited | 19.64 Billion INR | 99.936% |
Lincoln Pharmaceuticals Limited | 1.88 Billion INR | 99.335% |
Lupin Limited | 125.09 Billion INR | 99.99% |
Mangalam Drugs & Organics Limited | 691.19 Million INR | 98.185% |
Medico Remedies Limited | 262.14 Million INR | 95.214% |
Morepen Laboratories Limited | 6.16 Billion INR | 99.796% |
Nectar Lifesciences Limited | 4.82 Billion INR | 99.74% |
Orchid Pharma Limited | 2.32 Billion INR | 99.459% |
Procter & Gamble Health Limited | 5.78 Billion INR | 99.783% |
RPG Life Sciences Limited | 2.48 Billion INR | 99.495% |
Kilitch Drugs (India) Limited | 620.47 Million INR | 97.978% |
Sigachi Industries Limited | 2 Billion INR | 99.373% |
Solara Active Pharma Sciences Limited | -1.65 Billion INR | 100.758% |
Suven Pharmaceuticals Limited | 4.12 Billion INR | 99.696% |
Themis Medicare Limited | 2.42 Billion INR | 99.482% |
Unichem Laboratories Limited | 4.86 Billion INR | 99.742% |
Vaishali Pharma Limited | 90.32 Million INR | 86.111% |
Wanbury Limited | 1.73 Billion INR | 99.275% |
Windlas Biotech Limited | 1.33 Billion INR | 99.063% |
ZIM Laboratories Limited | 1.26 Billion INR | 99.011% |
Ind-Swift Laboratories Limited | 4.13 Billion INR | 99.696% |
Ipca Laboratories Limited | 48.58 Billion INR | 99.974% |
Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 99.995% |
Venus Remedies Limited | 2.18 Billion INR | 99.425% |
Sakar Healthcare Limited | 699.58 Million INR | 98.207% |
Aurobindo Pharma Limited | 109.54 Billion INR | 99.989% |
Divi's Laboratories Limited | 32.44 Billion INR | 99.961% |
AstraZeneca Pharma India Limited | 6.22 Billion INR | 99.798% |
Mankind Pharma Limited | 42.19 Billion INR | 99.97% |
Sequent Scientific Limited | 2.97 Billion INR | 99.579% |
Laurus Labs Limited | 15.44 Billion INR | 99.919% |
Neuland Laboratories Limited | 8.24 Billion INR | 99.848% |
J. B. Chemicals & Pharmaceuticals Limited | 15.25 Billion INR | 99.918% |
Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 99.982% |
Zydus Lifesciences Limited | 125.21 Billion INR | 99.99% |
Amrutanjan Health Care Limited | 2.09 Billion INR | 99.401% |
Wockhardt Limited | 7.72 Billion INR | 99.838% |
Bal Pharma Limited | 770.19 Million INR | 98.371% |
Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 99.992% |
Bliss GVS Pharma Limited | 3.69 Billion INR | 99.661% |
Par Drugs and Chemicals Limited | 529.13 Million INR | 97.629% |
Caplin Point Laboratories Limited | 9.2 Billion INR | 99.864% |
Shilpa Medicare Limited | 3.56 Billion INR | 99.648% |
Valiant Laboratories Limited | 138.02 Million INR | 90.911% |
Ajanta Pharma Limited | 21.06 Billion INR | 99.94% |
Aarey Drugs & Pharmaceuticals Limited | 113.02 Million INR | 88.901% |
Granules India Limited | 16.79 Billion INR | 99.925% |
Medicamen Biotech Limited | 495.49 Million INR | 97.468% |
Syncom Formulations (India) Limited | 559.5 Million INR | 97.758% |
Piramal Enterprises Limited | 8.04 Billion INR | 99.844% |
Torrent Pharmaceuticals Limited | 46.75 Billion INR | 99.973% |
NATCO Pharma Limited | 25.73 Billion INR | 99.951% |
Suven Life Sciences Limited | -200.79 Million INR | 106.248% |
Krebs Biochemicals & Industries Limited | -108.74 Million INR | 111.536% |
Strides Pharma Science Limited | 14.38 Billion INR | 99.913% |
Indoco Remedies Limited | 8.04 Billion INR | 99.844% |
Alpa Laboratories Limited | 188.89 Million INR | 93.359% |
Lasa Supergenerics Limited | 121.02 Million INR | 89.635% |
Sun Pharma Advanced Research Company Limited | 391.06 Million INR | 96.792% |